Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
13.13
+0.06 (0.46%)
Sep 8, 2025, 3:04 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Preparation
2.99B
Log In
Log In
Log In
Log In
Upgrade
Preparation Growth
0.24%
Log In
Log In
Log In
Log In
Upgrade
API
1.07B
Log In
Log In
Log In
Log In
Upgrade
API Growth
-18.23%
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Operations
1.03B
Log In
Log In
Log In
Log In
Upgrade
Contract Development and Manufacturing Operations Growth
6.91%
Log In
Log In
Log In
Log In
Upgrade
Other
191.54M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-0.13%
Log In
Log In
Log In
Log In
Upgrade
Trypsin and Other
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2010 - 2019
Europe
2.37B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-9.28%
Log In
Log In
Log In
Log In
Upgrade
United States
1.43B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
11.99%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
1.11B
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
-1.11%
Log In
Log In
Log In
Log In
Upgrade
China
360.55M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-12.58%
Log In
Log In
Log In
Log In
Upgrade
Hong Kong
7.20M
Log In
Log In
Log In
Log In
Upgrade
Hong Kong Growth
-60.19%
Log In
Log In
Log In
Log In
Upgrade